Illinois law on drug diversion comes from three sources: the Illinois Controlled Substances Act, 720 ILCS 570, which holds the criminal offences and the Prescription Monitoring Program; the Pharmacy Practice Act, 225 ILCS 85, which gives the Department of Financial and Professional Regulation its disciplinary powers over pharmacists, pharmacies and technicians; and Part 1330 of Title 68 of the Illinois Administrative Code, the Department's pharmacy rules. In Illinois the licensing authority is the Department rather than a free-standing board, so the sanction decisions below are the Department's. Each statement links to the text it comes from.

Statutes: the Controlled Substances Act and the Pharmacy Practice Act

Section 406 of the Controlled Substances Act lists the offences that matter most for records and acquisition. Under subsection (b) it is unlawful for any person knowingly to acquire or obtain, or attempt to acquire or obtain, possession of a controlled substance by misrepresentation, fraud, forgery, deception or subterfuge; to withhold information requested by a practitioner with the intent to obtain a controlled substance that has not been prescribed; or to furnish false or fraudulent material information in, or omit any material information from, any application, report or other document, or any record, required to be kept under the Act [1]. Subsection (a)(3) separately prohibits refusing or failing to make, keep or furnish any record, notification, order form, statement, invoice or information required under the Act [1].

Section 30 of the Pharmacy Practice Act sets the grounds for discipline. They include violating the Act or its rules, conviction of a felony or of a misdemeanour that involves controlled substances or is directly related to the practice of pharmacy, habitual or excessive use or addiction to alcohol, narcotics or other drugs that results in an inability to practise with reasonable judgment, skill or safety, and willfully making or filing false records or reports in the practice of pharmacy [2]. Item 18 covers dispensing prescription drugs without receiving a written or oral prescription in violation of law, and item 22 covers failing to sell or dispense any drug in good faith [2].

The ground that matters most to an inventory investigation is item 19: a finding of a substantial discrepancy in a Department audit of a prescription drug, including controlled substances [2]. The item is a ground in its own right, listed separately from the grounds that require a conviction or proof of dishonesty.

Board rules: security and the pharmacy's duties

The Department's security rule is short. Under section 1330.600, whenever the pharmacy prescription area is not occupied by a registrant it must be secured and inaccessible to non-licensed persons, employees and public alike. The rule says this may be accomplished by measures such as walling off, locking doors or electronic security equipment, as approved by the Division [3].

Section 1330.500 adds staffing and records rules for community pharmacies. No prescription may be dispensed when a pharmacist is not physically present in the establishment. For every prescription dispensed, the prescription record must contain the name, initials or other unique identifier of the pharmacist who dispenses it, and when a technician dispenses under supervision the record must name both the supervising pharmacist and the technician [4].

Penalties: criminal, licence and civil

The Controlled Substances Act grades section 406 by subsection. A violation of subsection (b), including obtaining a controlled substance by fraud or falsifying a required record, is a Class 4 felony for the first offence and a Class 3 felony for each subsequent offence. The fine for the first offence is not more than $100,000 and for each subsequent offence not more than $200,000 [1]. A violation of subsection (a), including failing to keep a required record, is a Class A misdemeanour for the first offence and a Class 4 felony for each subsequent offence, with a fine for each subsequent offence of not more than $100,000. A practitioner found guilty under subsection (a) is also subject to suspension and revocation of the professional licence [1].

On the licence side, section 30(a) of the Pharmacy Practice Act lets the Department refuse to issue or renew a licence, revoke it, suspend it, place it on probation, fine, or take any other disciplinary or non-disciplinary action it deems proper, including fines not to exceed $10,000 for each violation [2]. A conviction counts for discipline whether it follows a plea of guilty or nolo contendere, a finding of guilt, a jury verdict, or sentencing that includes supervision, conditional discharge or first offender probation [2].

Rule 1330.710 attaches a consequence to failing to copy the Department on a theft report. Failure to send the copy may result in discipline of the pharmacy or the pharmacist-in-charge [5]. Failure to report to the Prescription Monitoring Program carries a civil fine under section 316 of up to $100 per day for willful failure, calculated from the time the report was required until the problem was resolved [6].

Reporting duties and deadlines

The Illinois theft-reporting rule is built on the federal one. Under section 1330.710, in every instance that a pharmacy is required by federal regulation (21 C.F.R. 1301.76) to file a Report of Theft or Loss of Controlled Substances (DEA Form 106) with the Drug Enforcement Administration, a copy shall concurrently be sent to the Division, attention of the Drug Compliance Unit, along with the printed name of the person who signed the form [5]. The rule sets no separate deadline: the Illinois copy is due when the federal filing is.

Section 30 of the Pharmacy Practice Act adds two reporting clocks for licensees. Failing, within 60 days, to respond to a written request made by the Department for information is a ground for discipline, and so is failing to report within 60 days any adverse final action taken against the licensee by another licensing jurisdiction, a governmental agency, a law enforcement agency or a court for conduct similar to the grounds in the section [2].

Dispensing data has a same-day deadline. Section 316(a)(2) requires the dispenser to transmit the required information not later than the end of the business day on which a controlled substance is dispensed, or at such other time as the Department requires by rule, and section 316(a)(3) requires the transmission to be electronic [6]. Failing to keep and furnish records the Act requires is also a section 406 offence, as above [1].

Monitoring: the Prescription Monitoring Program

Section 316 requires the Department to provide a Prescription Monitoring Program for Schedule II, III, IV and V controlled substances, except testosterone. The dispenser must transmit to the central repository the recipient's name, address, date of birth and gender, the national drug code, the quantity and days' supply, the dispenser's and prescriber's DEA numbers, the dates filled and the payment type [6]. Veterinarians are exempt from the reporting requirement, although a veterinarian who suspects an animal's owner of fraudulently obtaining a controlled substance must report that to local law enforcement [6].

Section 316(f) also puts the responsibility on any new, ceased or unconnected healthcare facility and its pharmacy management system to make contact with and integrate with the Program, and directs the Department to adopt rules requiring electronic health records and pharmacy management systems to interface with it [6].

For impaired pharmacists, the disciplinary grounds in section 30 are habitual or excessive use or addiction to alcohol, narcotics, stimulants or any other chemical agent or drug, and physical or mental illness or any other impairment or disability that results in an inability to practise with reasonable judgment, skill or safety [2]. The sources read for this page do not describe a treatment or monitoring programme for impaired pharmacists, so none is described here.

Sources

Each link below was fetched on 15 November 2026 and returned HTTP 200. Bracketed numbers in the text open the same pages.

  1. 720 ILCS 570/406, Illinois Controlled Substances Act, Section 406
  2. 225 ILCS 85/30, Pharmacy Practice Act, Section 30, Refusal, revocation, suspension, or other discipline
  3. 68 Ill. Adm. Code 1330.600, Security Requirements
  4. 68 Ill. Adm. Code 1330.500, Community Pharmacy Services
  5. 68 Ill. Adm. Code 1330.710, Reporting Theft or Loss of Controlled Substances (Cornell LII)
  6. 720 ILCS 570/316, Illinois Controlled Substances Act, Section 316, Prescription Monitoring Program

Scope. This page summarises statutes and rules as read in November 2026 and is not legal advice. The statute pages come from the Illinois General Assembly's site; the section 1330.710 text was read on Cornell's Legal Information Institute copy and section 1330.500 and 1330.600 on the General Assembly's administrative code pages. The General Assembly's web server presents an incomplete TLS certificate chain, so those pages were read with certificate verification relaxed for that host only. The page does not cover the rest of Part 1330, the Department's disciplinary guidelines, federal DEA requirements, or amendments made after the versions read. Check the current text and the Department's guidance before relying on a deadline or penalty.

Related pages

Would your controls meet these duties?

The free self-assessment scores your own controls: 7 sections, 45 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.

Start the free assessment

Would your controls meet these duties?

The free self-assessment scores your own controls: 7 sections, 45 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.

Start the free assessment